Respiratory News and Research

RSS

Physical activity linked with better lung function in smokers, regardless of air pollution levels

Regular physical activity is associated with better lung function among current smokers in European cities, regardless of air pollution levels.

11 Oct 2018

Flavoring, additive ingredients in e-cigarettes may increase inflammation and impair lung function

Flavoring and additive ingredients in e-cigarettes may increase inflammation and impair lung function, according to new research.

11 Oct 2018

Teva announces European launch of patient-centric website

Teva Pharmaceutical Industries Ltd. today announced the European launch of Life Effects, a patient-centric website hosting content created by patients and checked by experts, at the European Committee for the Treatment and Research of Multiple Sclerosis Congress in Berlin.

11 Oct 2018

New hope for children with aggressive form of cancer

Children with an aggressive form of cancer are being given new hope in a world-first trans-Atlantic clinical trial that will test a new three-part treatment.

10 Oct 2018

Spurred by convenience, millennials often spurn the ‘family doctor’ model

Calvin Brown doesn’t have a primary care doctor — and the peripatetic 23-year-old doesn’t want one.

9 Oct 2018

Children with asthma have higher risk of obesity

Toddlers with asthma are more likely to become obese children, according to an international study led by USC scientists.

9 Oct 2018

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.

8 Oct 2018

Study identifies risk factors of maternal mortality in mechanically ventilated pregnant patients

Researchers in Columbia, South America, conducted a retrospective observational study within six hospitals to identify risk factors of maternal mortality in mechanically ventilated pregnant patients.

5 Oct 2018

Study demonstrates benefits of using triple dual therapies in patients with COPD

The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.

5 Oct 2018

Gram-negative bacteria found to be risk factor for worse outcomes in hospitalized ILD patients

Alterations to the respiratory microbiome have been identified as a predisposing factor of interstitial lung diseases. In a study at CHEST 2018, researchers at Beaumont Health Systems studied the influence of bacterial virulence on clinical outcomes patients hospitalized with ILD patients.

4 Oct 2018

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

4 Oct 2018

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Genentech, a member of the Roche Group, announced today interim clinical data from the dose-finding parts of the pivotal FIREFISH and SUNFISH studies investigating risdiplam in spinal muscular atrophy.

3 Oct 2018

ATS releases new guideline to help clinicians manage malignant pleural effusions

A new guideline to help clinicians manage malignant pleural effusions has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology.

3 Oct 2018

Disruption in combination inhaled corticosteroid therapy may impact patients' symptoms and disease control

Disruption of the refill of patients' regular combination inhaled corticosteroid therapy brand may have impacted symptoms and disease control and potentially lead to an increased rate of costly exacerbations and hospitalizations.

2 Oct 2018

Researchers find link between insufficient sleep and unsafe behavior in teens

Adolescents require 8-10 hours of sleep at night for optimal health, according to sleep experts, yet more than 70 percent of high school students get less than that.

1 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.

1 Oct 2018

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.

29 Sep 2018

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.

29 Sep 2018

Acne stigma associated with impaired psychological and physical well-being

Many people with acne are negatively impacted by perceived social stigma around the skin condition, a new study from University of Limerick, Ireland, has found.

28 Sep 2018

Respiratory News and Research

Physical activity linked with better lung function in smokers, regardless of air pollution levels

Flavoring, additive ingredients in e-cigarettes may increase inflammation and impair lung function

Teva announces European launch of patient-centric website

New hope for children with aggressive form of cancer

Spurred by convenience, millennials often spurn the ‘family doctor’ model

Children with asthma have higher risk of obesity

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Study identifies risk factors of maternal mortality in mechanically ventilated pregnant patients

Study demonstrates benefits of using triple dual therapies in patients with COPD

Gram-negative bacteria found to be risk factor for worse outcomes in hospitalized ILD patients

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

ATS releases new guideline to help clinicians manage malignant pleural effusions

Disruption in combination inhaled corticosteroid therapy may impact patients' symptoms and disease control

Researchers find link between insufficient sleep and unsafe behavior in teens

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

Acne stigma associated with impaired psychological and physical well-being

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News